Aldeyra Therapeutics, Inc.
ALDX •
Sell Closed
Signal type
Sell
Status
Closed
Open Price
$4.01
Closed Price
$1.79
Performance
55.36%
Days Open
32
Signal Setup
Signal Type Sell
Status Closed
Open Date Mar 13, 2026
Open Price $4.01
Stop Loss $4.64
Timespan Day
Trade Outcome
Closed Status Profit
Closed Date Apr 14, 2026
Closed Price $1.79
Performance 55.36%
Days Open 32
Company Profile
Name Aldeyra Therapeutics, Inc.
Ticker ALDX
Market Cap $229.40M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $1.79
List Date May 2, 2014
Description
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Website Open Company Website